BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7814348)

  • 1. Behavioral effects of trazodone in Alzheimer's disease.
    Lebert F; Pasquier F; Petit H
    J Clin Psychiatry; 1994 Dec; 55(12):536-8. PubMed ID: 7814348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
    Kitamura Y; Kudo Y; Imamura T
    No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacy.
    Claus JJ; de Koning I; van Harskamp F; Breteler MM; Voet B; Gutzmann H; Dahlke F; van der Cammen T; Hofman A
    Clin Neuropharmacol; 1998; 21(3):190-5. PubMed ID: 9617511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study.
    Guétin S; Portet F; Picot MC; Pommié C; Messaoudi M; Djabelkir L; Olsen AL; Cano MM; Lecourt E; Touchon J
    Dement Geriatr Cogn Disord; 2009; 28(1):36-46. PubMed ID: 19628939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early-onset Alzheimer's disease: comparison with senile dementia of Alzheimer's type.
    Hori K; Oda T; Asaoka T; Yoshida M; Watanabe S; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):730-5. PubMed ID: 16401251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.